about
Peptide Inhibition of Topoisomerase IB from Plasmodium falciparum.Economic evidence for the clinical management of major depressive disorder: a systematic review and quality appraisal of economic evaluations alongside randomised controlled trials.Droplet microfluidics platform for highly sensitive and quantitative detection of malaria-causing Plasmodium parasites based on enzyme activity measurement.Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented?Socio-economic burden of rare diseases: A systematic review of cost of illness evidence.Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey.Topoisomerase I deficiency results in chromosomal alterations in cervical cancer cells.Deciphering the structural properties that confer stability to a DNA nanocage.Variant Plasmodium ovale isolated from a patient infected in Ghana.Structure of nanoscale truncated octahedral DNA cages: variation of single-stranded linker regions and influence on assembly yields.RARE-Bestpractices: a platform for sharing best practices for the management of rare diseases.PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION.Availability of medical supplies during the 2010 Pakistan floods.Consolidated research agenda needed for health economic evaluation in Europe.Is the Funding of Public National Health Systems Sustainable over the Long Term? Evidence from Eight OECD CountriesComponents of Sustainable Health Systems: What Is Known About The Cost-Effectiveness of Clinical Care?Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology.Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30
P50
Q35431209-F939B562-7DE4-45EE-874C-43FBBC611D33Q36058199-FFC1B5E9-3172-4CDE-8B19-7F08C513DE96Q36484441-B1414389-9AFA-484C-9D58-B110B4756C98Q38185481-261C7615-8962-466A-B481-FE55F688E43FQ38347885-B94E8F06-2BC8-4FD9-9A27-0A9010B77A2BQ39331974-FE597D39-A434-451A-9602-2C6EF0169219Q39644706-5C005544-4409-4CD9-86E0-4C3B8295267EQ41620887-056F4CE9-9098-42E2-B758-8D9C8EC14D74Q41933838-EC7FC309-A6BC-4B36-8B7F-72BA3F22D245Q43166366-AE08B7DC-707D-41EE-B184-80E8133F94C0Q46677333-6158B64F-46EE-4791-A361-D72F8363F574Q47635473-688CB65F-6E44-4A38-8745-70D388E59803Q54265427-536E6CA5-A656-430D-A8A2-5AF5BFB27473Q54782062-7C15771B-4CAD-46C7-82EB-0CC21B51F8AEQ60473189-489966E8-4098-4C22-A7B6-C091929A72ABQ60473191-3802E0D4-0A46-4C35-BE16-1F716EC390B8Q64933988-439FB094-0D04-4B69-8F2B-F7E699BA1A3CQ92229547-A10347B1-CDBD-4A8C-A2B0-822DCC4269A0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David Tordrup
@ast
David Tordrup
@en
David Tordrup
@es
David Tordrup
@nl
type
label
David Tordrup
@ast
David Tordrup
@en
David Tordrup
@es
David Tordrup
@nl
prefLabel
David Tordrup
@ast
David Tordrup
@en
David Tordrup
@es
David Tordrup
@nl
P106
P21
P31
P496
0000-0002-7779-9303